Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
health risk assessments
Common genotyping method frequently misidentifies very rare pathogenic variants
By
Dave Muoio
|
02:56 pm |
February 16, 2021
SNP chip data often reported by consumer genomics companies should not be considered for clinical decisions without additional validation, warn researchers.